Graff, S. http://orcid.org/0000-0002-2060-689X
Vanwynsberghe, S.
Brusselle, G.
Hanon, S.
Sohy, C.
Dupont, L. J.
Peche, R.
Michils, A.
Pilette, C.
Joos, G.
Louis, R. E.
Schleich, F. N.
Funding for this research was provided by:
European Union
Interuniversity Attraction Poles Program (Belgian Science Policy (P7/30))
Article History
Received: 28 May 2020
Accepted: 17 July 2020
First Online: 12 August 2020
Ethics approval and consent to participate
: CHU Liège: 2008/221.
: Not applicable.
: Dr. Graff has nothing to disclose.Dr. Vanwynsberghe has nothing to disclose.Dr. Brusselle reports personal fees from Astra Zeneca, personal fees from Boehringer-Ingelheim, personal fees from Chiesi, personal fees from GlaxoSmithKline, personal fees from Novartis, personal fees from Sanofi, personal fees from Teva, outside the submitted work.Dr. Hanon has nothing to disclose.Dr. Sohy has nothing to disclose.Dr. Dupont has nothing to disclose.Dr. Peche has nothing to disclose.Dr. Michils reports grants, personal fees and other from Astrazeneca, grants, personal fees and other from Chiesi, grants and personal fees from GSK, personal fees from Novartis, outside the submitted work.Dr. Pilette has nothing to disclose.Dr. JOOS reports grants from AstraZeneca, personal fees from Bayer, grants from Chiesi, personal fees from Eureca vzw, grants and personal fees from GlaxoSmithKline, personal fees from Teva, outside the submitted work; all fees were paid to the department.Dr. LOUIS reports grants and personal fees from GSK, grants and personal fees from AZ, grants and personal fees from Novartis, grants from Chiesi, outside the submitted work.Dr. Schleich has nothing to disclose.